140 related articles for article (PubMed ID: 18774472)
1. Surveillance for renal cell carcinoma: why and how? When and how often?
Klatte T; Lam JS; Shuch B; Belldegrun AS; Pantuck AJ
Urol Oncol; 2008; 26(5):550-4. PubMed ID: 18774472
[TBL] [Abstract][Full Text] [Related]
2. Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system.
Lam JS; Shvarts O; Leppert JT; Pantuck AJ; Figlin RA; Belldegrun AS
J Urol; 2005 Aug; 174(2):466-72; discussion 472; quiz 801. PubMed ID: 16006866
[TBL] [Abstract][Full Text] [Related]
3. Postoperative surveillance for renal cell carcinoma: a multifactorial histological subtype specific protocol.
Siddiqui SA; Frank I; Cheville JC; Lohse CM; Leibovich BC; Blute ML
BJU Int; 2009 Sep; 104(6):778-85. PubMed ID: 19338559
[TBL] [Abstract][Full Text] [Related]
4. A review on follow-up strategies for renal cell carcinoma after nephrectomy.
Skolarikos A; Alivizatos G; Laguna P; de la Rosette J
Eur Urol; 2007 Jun; 51(6):1490-500; discussion 1501. PubMed ID: 17229521
[TBL] [Abstract][Full Text] [Related]
5. Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study.
Patard JJ; Kim HL; Lam JS; Dorey FJ; Pantuck AJ; Zisman A; Ficarra V; Han KR; Cindolo L; De La Taille A; Tostain J; Artibani W; Dinney CP; Wood CG; Swanson DA; Abbou CC; Lobel B; Mulders PF; Chopin DK; Figlin RA; Belldegrun AS
J Clin Oncol; 2004 Aug; 22(16):3316-22. PubMed ID: 15310775
[TBL] [Abstract][Full Text] [Related]
6. Patterns of recurrence and surveillance strategies for renal cell carcinoma following surgical resection.
Breda A; Konijeti R; Lam JS
Expert Rev Anticancer Ther; 2007 Jun; 7(6):847-62. PubMed ID: 17555395
[TBL] [Abstract][Full Text] [Related]
7. [External validation of the University of Los Angeles Integrated Staging System (UISS) in localized renal cell carcinoma: single center study].
Onea C; Mouracade P; Roman H; Wagner B; Saussine C; Jacqmin D; Lang H
Prog Urol; 2010 Jan; 20(1):35-9. PubMed ID: 20123526
[TBL] [Abstract][Full Text] [Related]
8. Incidentally discovered renal masses: oncological and perioperative outcomes in patients with delayed surgical intervention.
Rais-Bahrami S; Guzzo TJ; Jarrett TW; Kavoussi LR; Allaf ME
BJU Int; 2009 May; 103(10):1355-8. PubMed ID: 19239459
[TBL] [Abstract][Full Text] [Related]
9. Brain metastasis from renal cell carcinoma: presentation, recurrence, and survival.
Shuch B; La Rochelle JC; Klatte T; Riggs SB; Liu W; Kabbinavar FF; Pantuck AJ; Belldegrun AS
Cancer; 2008 Oct; 113(7):1641-8. PubMed ID: 18671240
[TBL] [Abstract][Full Text] [Related]
10. Functional and oncological outcomes of partial nephrectomy of solitary kidneys.
La Rochelle J; Shuch B; Riggs S; Liang LJ; Saadat A; Kabbinavar F; Pantuck A; Belldegrun A
J Urol; 2009 May; 181(5):2037-42; discussion 2043. PubMed ID: 19298974
[TBL] [Abstract][Full Text] [Related]
11. Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases.
Amin MB; Paner GP; Alvarado-Cabrero I; Young AN; Stricker HJ; Lyles RH; Moch H
Am J Surg Pathol; 2008 Dec; 32(12):1822-34. PubMed ID: 18813125
[TBL] [Abstract][Full Text] [Related]
12. Outcomes following partial nephrectomy by tumor size.
Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
[TBL] [Abstract][Full Text] [Related]
13. Prognostic models and algorithms in renal cell carcinoma.
Lane BR; Kattan MW
Urol Clin North Am; 2008 Nov; 35(4):613-25; vii. PubMed ID: 18992615
[TBL] [Abstract][Full Text] [Related]
14. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.
Margulis V; McDonald M; Tamboli P; Swanson DA; Wood CG
J Urol; 2009 May; 181(5):2044-51. PubMed ID: 19286220
[TBL] [Abstract][Full Text] [Related]
15. The 'Stage, Size, Grade and Necrosis' score is more accurate than the University of California Los Angeles Integrated Staging System for predicting cancer-specific survival in patients with clear cell renal cell carcinoma.
Ficarra V; Novara G; Galfano A; Brunelli M; Cavalleri S; Martignoni G; Artibani W
BJU Int; 2009 Jan; 103(2):165-70. PubMed ID: 18782313
[TBL] [Abstract][Full Text] [Related]
16. Urinary collecting system invasion is an independent prognostic factor of organ confined renal cell carcinoma.
Verhoest G; Avakian R; Bensalah K; Thuret R; Ficarra V; Artibani W; Tostain J; Guille F; Cindolo L; De La Taille A; Abbou CC; Salomon L; Rioux-Leclercq N; Patard JJ
J Urol; 2009 Sep; 182(3):854-9. PubMed ID: 19616244
[TBL] [Abstract][Full Text] [Related]
17. EORTC-GU group expert opinion on metastatic renal cell cancer.
de Reijke TM; Bellmunt J; van Poppel H; Marreaud S; Aapro M
Eur J Cancer; 2009 Mar; 45(5):765-73. PubMed ID: 19157861
[TBL] [Abstract][Full Text] [Related]
18. Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy.
Klatte T; Seligson DB; LaRochelle J; Shuch B; Said JW; Riggs SB; Zomorodian N; Kabbinavar FF; Pantuck AJ; Belldegrun AS
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):894-900. PubMed ID: 19240241
[TBL] [Abstract][Full Text] [Related]
19. Renal cell carcinoma in children: single-center experience.
Helmy T; Sarhan O; Sarhan M; El-Baz M; Dawaba M; Ghali A
J Pediatr Surg; 2009 Sep; 44(9):1750-3. PubMed ID: 19735820
[TBL] [Abstract][Full Text] [Related]
20. Perinephric and renal sinus fat infiltration in pT3a renal cell carcinoma: possible prognostic differences.
Bedke J; Buse S; Pritsch M; Macher-Goeppinger S; Schirmacher P; Haferkamp A; Hohenfellner M
BJU Int; 2009 May; 103(10):1349-54. PubMed ID: 19076147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
